Activated microglia in the retina are essential for the development of autoimmune uveitis. Yin-Yang 1 (YY1) is an important transcription factor that participates in multiple inflammatory and immune-mediated diseases. Here, an increased YY1 lactylation in retinal microglia within in the experimental autoimmune uveitis (EAU) group is observed. YY1 lactylation contributed to boosting microglial activation and promoting their proliferation and migration abilities. Inhibition of lactylation suppressed microglial activation and attenuated inflammation in EAU. Mechanistically, cleavage under targets & tagmentation (CUT&Tag? analysis revealed that YY1 lactylation promoted microglial activation by regulating the transcription of a set of inflammatory genes, including STAT3, CCL5, IRF1, IDO1, and SEMA4D. In addition, p300 is identified as the writer of YY1 lactylation. Inhibition of p300 decreased YY1 lactylation and suppressed microglial inflammation in vivo and in vitro. Collectively, the results showed that YY1 lactylation promoted microglial dysfunction in autoimmune uveitis by upregulating inflammatory cytokine secretion and boosting cell migration and proliferation. Therapeutic effects can be achieved by targeting the lactate/p300/YY1 lactylation/inflammatory genes axis. This study reveals that YY1 lactylation promotes microglial functions in autoimmune uveitis by upregulating inflammatory cytokine secretion and boosting cell migration and proliferation. Therefore, inhibiting YY1 lactylation genetically or pharmacologically alleviates symptoms of EAU and mitigates activation of microglia, indicating that therapeutic effects can be achieved by targeting the lactate/p300/YY1 lactylation and inflammatory gene (IRF1/IDO1/SEMA4D/CCL5/STAT3) axis. image
基金:
National Natural Science Foundation [82070951, 82271078, 82371045]; National Natural Science Foundation Project of China [JYY2023-6]; Beijing Municipal Public Welfare Development and Reform Pilot Project for Medical Research Institutes; National Key Clinical Specialties Construction Program of China, Chongqing Branch of National Clinical Research Center for Ocular Diseases [2008CA5003]; Chongqing Key Laboratory of Ophthalmology (CSTC)